Literature DB >> 26985853

Teledermatology and clinical photography: safeguarding patient privacy and mitigating medico-legal risk.

Paul Stevenson1, Anna R Finnane2, H Peter Soyer2.   

Abstract

Capturing clinical images is becoming more prevalent in everyday clinical practice, and dermatology lends itself to the use of clinical photographs and teledermatology. "Store-and-forward", whereby clinical images are forwarded to a specialist who later responds with an opinion on diagnosis and management is a popular form of teledermatology. Store-and-forward teledermatology has proven accurate and reliable, accelerating the process of diagnosis and treatment and improving patient outcomes. Practitioners' personal smartphones and other devices are often used to capture and communicate clinical images. Patient privacy can be placed at risk with the use of this technology. Practitioners should obtain consent for taking images, explain how they will be used, apply appropriate security in their digital communications, and delete images and other data on patients from personal devices after saving these to patient health records. Failing to use appropriate security precautions poses an emerging medico-legal risk for practitioners.

Entities:  

Mesh:

Year:  2016        PMID: 26985853     DOI: 10.5694/mja15.00996

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

1.  [Teledermoscopy by mobile phones : Reliable help in the diagnosis of skin lesions?]

Authors:  A Zink; A Kolbinger; M Leibl; I Léon Suarez; J Gloning; C Merkel; J Winkler; T Biedermann; J Ring; B Eberlein
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

2.  Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption?

Authors:  Robin H Wang; John S Barbieri; Harrison P Nguyen; Robert Stavert; Howard P Forman; Jean L Bolognia; Carrie L Kovarik
Journal:  J Am Acad Dermatol       Date:  2020-02-05       Impact factor: 11.527

3.  Patient and practitioner satisfaction with tele-dermatology including Australia's indigenous population: A systematic review of the literature.

Authors:  Emily K Kozera; Anes Yang; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2016-08-09

4.  Exploring practices of Dermatologists in Ethical Dilemmas in Pakistan: A narrative analysis.

Authors:  Moizza Tahir; Rahila Yasmeen; Rehan Ahmed Khan
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

5.  Recent trends in teledermatology and teledermoscopy.

Authors:  Katie J Lee; Anna Finnane; H Peter Soyer
Journal:  Dermatol Pract Concept       Date:  2018-07-31

6.  Attitudes and perceived barriers toward store-and-forward teledermatology among primary care providers of the rural Mississippi.

Authors:  Summer Morrissette; Ross L Pearlman; Margaret Kovar; William T Sisson; Robert T Brodell; Vinayak K Nahar
Journal:  Arch Dermatol Res       Date:  2021-02-25       Impact factor: 3.017

Review 7.  Teledermatology in the time of COVID-19.

Authors:  Ahmed Elsayed Ibrahim; Mayar Magdy; Eslam M Khalaf; Alshimaa Mostafa; Ahmed Arafa
Journal:  Int J Clin Pract       Date:  2021-11-04       Impact factor: 3.149

8.  Reshaping wound care: Evaluation of an artificial intelligence app to improve wound assessment and management amid the COVID-19 pandemic.

Authors:  Michelle Barakat-Johnson; Aaron Jones; Mitch Burger; Thomas Leong; Astrid Frotjold; Sue Randall; Bora Kim; Judith Fethney; Fiona Coyer
Journal:  Int Wound J       Date:  2022-02-25       Impact factor: 3.099

Review 9.  Workflow Challenges of Enterprise Imaging: HIMSS-SIIM Collaborative White Paper.

Authors:  Alexander J Towbin; Christopher J Roth; Mark Bronkalla; Dawn Cram
Journal:  J Digit Imaging       Date:  2016-10       Impact factor: 4.056

10.  Factors Determining the Success and Failure of eHealth Interventions: Systematic Review of the Literature.

Authors:  Conceição Granja; Wouter Janssen; Monika Alise Johansen
Journal:  J Med Internet Res       Date:  2018-05-01       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.